Intrepid Advises Aceto US, LLC, a Leading Provider of Specialty Chemicals, on Its Acquisitions of A&C and Cascade Chemistry

Intrepid announced today that it acted as advisor to Aceto US, LLC (Aceto) on its acquisitions of A&C and Cascade Chemistry. Founded in 1947, Port Washington, N.Y.-based Aceto is a leading provider of specialty materials to the life sciences and advanced technology end markets. A&C is a leading global GMP  manufacturer of specialty excipients, buffers, and process solutions to life sciences industries. Cascade Chemistry is a contract development and manufacturing organization (CDMO) that specializes in the manufacturing of active pharmaceutical ingredients (APIs) and advanced intermediates. Together these acquisitions expand Aceto’s North American footprint while adding drug development support and GMP manufacturing capabilities.

“We are honored to continue working alongside the Aceto team. These two highly-strategic acquisitions add key capabilities in support of Aceto’s long-term growth initiatives and raise the total number of transactions originated by Intrepid to three,” said Joseph Husband, Intrepid’s Director of Business Development.

Intrepid’s Buy-Side Advisory team conducts strategic acquisition searches for financial sponsors,  their portfolio companies and leading strategic acquirers in a wide variety of industries.

About Intrepid’s Buy-Side Advisory Group

Intrepid’s Buy-Side Advisory Group specializes in working across a wide variety of industries with private equity groups, private equity-backed portfolio companies, or large corporate acquirers to execute their acquisition strategies. Our team combines the expertise of buy-side search specialists, Intrepid’s dedicated industry coverage groups, and the relentless execution and quality of a premier investment bank. We have access to relationships and resources worldwide through our industry coverage groups, partnership with MUFG Union Bank, and involvement in Oaklins, a global middle-market investment consortium.